Abstract:Background: When a genetic mutation is identified in a family member (proband), internationally, it is usually the proband's or another responsible family member's role to disclose the information to at-risk relatives. However, both active and passive non-disclosure in families occurs: choosing not to communicate the information or failing to communicate the information despite intention to do so, respectively. The ethical obligations to prevent harm to at-risk relatives and promote the duty of care by genetic health professionals (GHPs) is in conflict with Privacy laws and professional regulations that prohibits disclosure of information to a third party without the consent of the proband (duty of confidentiality). In New South Wales (NSW), Australia, amendments to Privacy legislation permits such disclosure to living genetic relatives with the process defined under guidelines although there is no legal duty to warn. This study assessed NSW GHP's awareness and experience of the legislation and guidelines. Methods: An online survey collected demographics; theoretical knowledge; clinical scenarios to assess application knowledge; attitudes; confidence; experience with active non-disclosure. A link to correct answers was provided after completion. Knowledge scores above the median for non-parametric data or above the mean for parametric data were classified as 'good' or 'poor'. Chi square tests assessed associations between confidence and knowledge scores. Results: While many of the 37 participants reported reading the guidelines, there was limited awareness of their scope and clinical application; that there is no legal duty to warn; and that the threat does not need to be imminent to warrant disclosure. No association between confidence and 'good' theoretical or applied clinical knowledge was identified. Uncertainty of their professional responsibility was identified and in the several case examples of active non-disclosure that were reported this uncertainty reflected the need for further understanding of the guidelines in regard to the processes required before disclosure was initiated. Conclusions: There is a need for further education and training about the guidelines associated with the legislation that would be relevant to support disclosure. The findings may inform future strategies to support introduction of policy changes in other jurisdictions where similar regulatory regimes are introduced.

Breaching Confidentiality in Genetic and Non-Genetic Cases: Two Problematic Distinctions

Familial genetic risks: how can we better navigate patient confidentiality and appropriate risk disclosure to relatives?

From proband to provider: is there an obligation to inform genetic relatives of actionable risks discovered through direct-to-consumer genetic testing?

Clinician perspectives on policy approaches to genetic risk disclosure in families

Exploring genetic counselors' experiences with non‐paternity in clinical settings

Informing relatives of their genetic risk: an examination of the Belgian legal context

Confidentiality, privacy, and security of genetic and genomic test information in electronic health records: points to consider

Disclosure to genetic relatives without consent - Australian genetic professionals' awareness of the health privacy law

Professional duties are now considered legal duties of care within genomic medicine

Genetic privacy: orthodoxy or oxymoron?

Genetic Research: The Role of Citizens, Public Health and International Stakeholders

Disclosure of genetic risk to family members: A qualitative study on healthcare professionals' perceived roles and responsibilities

Attitudes Towards Non-directiveness Among Medical Geneticists in Germany and Switzerland

Enabling responsible public genomics

The law of genetic privacy: applications, implications, and limitations

Intersectionality, BRCA Genetic Testing, and Intrafamilial Communication of Risk: A Qualitative Study

The Right to Know and not to Know: Predictive Genetic Diagnosis and Non-diagnosis

How hereditary cancer risk disclosure to relatives is handled in practice - Patient perspectives from a Swedish cancer genetics clinic

Ethical Considerations on Pediatric Genetic Testing Results in Electronic Health Records

Evolving perspectives on genetic discrimination in health insurance among health care providers

The emergence of an ethical duty to disclose genetic research results: international perspectives